Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Medicinal Chemistry Of Therapeutic Peptides: Recent Developments In Synthesis And Design Optimizations.

Anutthaman Parthasarathy, Sasikala K Anandamma, Karunakaran Kalesh
Published 2017 · Computer Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Peptide therapeutics have made tremendous progress in the past decade. Many of the inherent weaknesses of peptides which hampered their development as therapeutics are now more or less effectively tackled with recent scientific and technological advancements in integrated drug discovery settings. These include recent developments in synthetic organic chemistry, high-throughput recombinant production strategies, high-resolution analytical methods, high-throughput screening options, ingenious drug delivery strategies and novel formulation preparations. Here, we will briefly describe the key methodologies and strategies used in the therapeutic peptide development processes with select examples of the most recent developments in the field. The aim of this review is to highlight the viable options a medicinal chemist may consider in order to improve a specific pharmacological property of interest in a peptide lead entity and thereby rationally assess the therapeutic potential this class of molecules possesses while they are traditionally (and incorrectly) considered 'undruggable'.
This paper references
10.1016/0304-3940(94)11163-D
Transfecting neurons and glia in the rat using pH-sensitive immunoliposomes
E. Geisert (1995)
10.1021/mp400619v
Enhanced Cellular Entry and Efficacy of Tat Conjugates by Rational Design of the Auxiliary Segment
P. Zhang (2014)
10.1016/j.addr.2015.12.001
Advancement in integrin facilitated drug delivery.
D. Arosio (2016)
10.1039/c1cc12570b
Drug release from hydrazone-containing peptide amphiphiles.
John B. Matson (2011)
10.1002/anie.201205674
N-methylation of peptides and proteins: an important element for modulating biological functions.
J. Chatterjee (2013)
10.1016/j.addr.2012.02.002
Polymer nanogels: a versatile nanoscopic drug delivery platform.
Reuben T Chacko (2012)
10.1007/s11095-011-0517-3
Controlled Release of Octreotide and Assessment of Peptide Acylation from Poly(D,L-lactide-co-hydroxymethyl glycolide) Compared to PLGA Microspheres
A. Ghassemi (2011)
10.1038/nchembio.1907
A biomimetic approach for enhancing the in vivo half-life of peptides
Sravan C Penchala (2015)
10.1016/S0005-2736(99)00068-1
Phase diagram of 1,2-dioleoylphosphatidylethanolamine (DOPE):water system at subzero temperatures and at low water contents.
E. Shalaev (1999)
10.1038/373049A0
Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH
G. Chen (1995)
10.1074/jbc.M401604200
Cellular Uptake of Unconjugated TAT Peptide Involves Clathrin-dependent Endocytosis and Heparan Sulfate Receptors*
Jean Philippe Richard (2005)
10.1002/1097-0290(20001220)70:6<593::AID-BIT1>3.0.CO;2-N
Receptor‐mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design
Csanad M. Varga (2000)
10.1038/nmeth.1272
Epitope mapping of antibodies using bacterial surface display
J. Rockberg (2008)
10.1039/b801634h
Azide monoliths as convenient flow reactors for efficient Curtius rearrangement reactions.
M. Baumann (2008)
10.1016/j.chembiol.2014.09.001
Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.
M. Arkin (2014)
10.1021/ja301017y
In Vitro Selection of Highly Modified Cyclic Peptides That Act as Tight Binding Inhibitors
Yollete V. Guillen Schlippe (2012)
10.1021/JA064479S
Oxidative Amide Synthesis and N-Terminal α-Amino Group Ligation of Peptides in Aqueous Medium
Wing-Kei Chan (2006)
10.1016/J.ADDR.2003.10.038
On the formulation of pH-sensitive liposomes with long circulation times.
S. Simões (2004)
10.1002/adma.201502598
In Situ Formation of Nanofibers from Purpurin18-Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites.
D. Zhang (2015)
10.1002/chem.201001642
Solid-phase synthesis of lipidated Ras peptides employing the Ellman sulfonamide linker.
Gemma Triola (2010)
10.1038/nbt1267
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
R. Hancock (2006)
10.1016/S1471-4906(02)02246-9
Mammalian defensins in immunity: more than just microbicidal.
D. Yang (2002)
10.1038/srep03468
Dual-Targeting Pro-apoptotic Peptide for Programmed Cancer Cell Death via Specific Mitochondria Damage
W. Chen (2013)
10.1021/NN302503S
Coassembled cytotoxic and pegylated peptide amphiphiles form filamentous nanostructures with potent antitumor activity in models of breast cancer.
Daniel J. Toft (2012)
10.1126/SCIENCE.1145295
Direct Synthesis of Amides from Alcohols and Amines with Liberation of H2
C. Gunanathan (2007)
10.1038/nature18941
Oxidative diversification of amino acids and peptides by small-molecule iron catalysis
Thomas J Osberger (2016)
10.1021/sb4001992
Rapid and reliable DNA assembly via ligase cycling reaction.
Stefan de Kok (2014)
10.1016/S0005-2736(01)00441-2
Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.
M. Turk (2002)
10.1371/journal.pone.0068016
Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism
C. Gründemann (2013)
10.1042/BST0350784
Arginine-rich peptides and their internalization mechanisms.
S. Futaki (2007)
10.1021/nn502201a
Engineering Persister-Specific Antibiotics with Synergistic Antimicrobial Functions
N. Schmidt (2014)
10.1007/s10989-011-9252-1
NickFects, Phosphorylated Derivatives of Transportan 10 for Cellular Delivery of Oligonucleotides
Nikita Oskolkov (2011)
10.1039/c6np00004e
Antimycin-type depsipeptides: discovery, biosynthesis, chemical synthesis, and bioactivities.
J. Liu (2016)
10.1021/BC980125H
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
10.1016/S0960-894X(01)80224-9
The chemical synthesis of large random peptide libraries and their use for the discovery of ligands for macromolecular acceptors
K. Lam (1993)
Liposomes as targetable drug carriers.
V. Torchilin (1985)
10.1093/bfgp/elr010
In vitro methods for peptide display and their applications.
Christopher G Ullman (2011)
10.4062/biomolther.2012.20.1.019
Cyclic Peptides as Therapeutic Agents and Biochemical Tools
S. Joo (2012)
10.1016/S1074-5521(02)00252-1
Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor.
Z. Hojati (2002)
10.1016/S0006-3495(04)74304-0
Self-association process of a peptide in solution: from beta-sheet filaments to large embedded nanotubes.
C. Valéry (2004)
10.1021/cb501020r
Hydrocarbon stapled peptides as modulators of biological function.
Philipp M Cromm (2015)
10.1021/JA064315B
Highly efficient oxidative amidation of aldehydes with amine hydrochloride salts.
Woo-Jin Yoo (2006)
10.1038/nrm3486
TALENs: a widely applicable technology for targeted genome editing
J. Joung (2013)
10.1016/J.CBPA.2004.04.007
'One bead two compound libraries' for detecting chemical and biochemical conversions.
M. Meldal (2004)
10.1016/0169-409X(95)00029-7
Pharmacokinetics of long-circulating liposomes
T. Allen (1995)
10.1021/ol200226z
Ring-closing metathesis approaches for the solid-phase synthesis of cyclic peptoids.
Sharaf Nawaz Khan (2011)
10.1016/j.synbio.2015.12.001
Informatic analysis reveals Legionella as a source of novel natural products
Chad W. Johnston (2016)
10.1039/c2cc17701c
Comparative proteomic profiling of mammalian cell lysates using phosphopeptide microarrays.
Liqian Gao (2012)
10.1016/J.JCONREL.2006.12.019
Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Kosuke Shigeta (2007)
10.1038/ncomms8160
New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
Lorena Mendive-Tapia (2015)
10.1016/S0005-2736(03)00050-6
Cytosolic delivery of macromolecules. II. Mechanistic studies with pH-sensitive morpholine lipids.
A. Asokan (2003)
10.2174/1381612033454900
Design of β-turn Based Therapeutic Agents
Kee Ks (2003)
10.1016/S0168-3659(02)00017-2
Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations.
Guangfeng Shi (2002)
10.1021/ja3115983
Supramolecular nanostructures formed by anticancer drug assembly.
A. G. Cheetham (2013)
10.1021/sb500351f
High-Efficiency Multiplex Genome Editing of Streptomyces Species Using an Engineered CRISPR/Cas System
R. Cobb (2015)
10.1039/c0cc05663d
Artificial lantipeptides from in vitro translations.
F. Seebeck (2011)
10.1016/J.CHEMBIOL.2007.10.015
Synthesis of polyester by means of genetic code reprogramming.
A. Ohta (2007)
10.1038/ncomms8013
Triangular prism-shaped β-peptoid helices as unique biomimetic scaffolds
Jonas S Laursen (2015)
10.1371/journal.pone.0003647
A One Pot, One Step, Precision Cloning Method with High Throughput Capability
C. Engler (2008)
10.1039/C5PY00584A
A pH-responsive drug delivery system with an aggregation-induced emission feature for cell imaging and intracellular drug delivery
H. Wang (2015)
10.1016/S0076-6879(00)28406-1
Phage display for selection of novel binding peptides.
S. Sidhu (2000)
10.1021/sb400058n
Refactoring the silent spectinabilin gene cluster using a plug-and-play scaffold.
Zengyi Shao (2013)
10.1038/nmeth1010
Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC
M. Li (2007)
10.1016/J.BBAMEM.2006.11.006
Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes.
R. Vandenbroucke (2007)
10.1023/B:PHAM.0000041463.56768.ec
Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo
C. Rudolph (2004)
10.1021/nn4057269
Cell-penetrating peptides: design, synthesis, and applications.
D. Copolovici (2014)
10.2174/0929866522666150622101944
Analogue of Melanotan II (MTII): A Novel Melanotropin with Superpotent Action on Frog Skin.
Liqian Gao (2015)
10.1016/J.TETLET.2011.12.002
Cyclization of peptoids by formation of boronate esters.
S. Chirayil (2012)
10.1208/s12249-011-9693-z
Sustained-Release Delivery of Octreotide from Biodegradable Polymeric Microspheres
Yun-Seok Rhee (2011)
10.1039/c3cs60273g
Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy.
V. Biju (2014)
10.1002/cmdc.200700159
Prodrug Strategies in Anticancer Chemotherapy
F. Kratz (2008)
10.1007/s00775-004-0560-1
Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent
N. Nitin (2004)
10.1021/JA00897A025
Solid phase peptide synthesis. I. the synthesis of a tetrapeptide
R. Merrifield (1963)
10.1039/b817853d
High-throughput screening of catalytically inactive mutants of protein tyrosine phosphatases (PTPs) in a phosphopeptide microarray.
H. Sun (2009)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1021/acs.jmedchem.5b01629
Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability.
J. Kaffy (2016)
10.1038/nprot.2011.331
Flexizymes for genetic code reprogramming
Y. Goto (2011)
10.1111/j.1747-0285.2010.00951.x
Probing the α‐Helical Structural Stability of Stapled p53 Peptides: Molecular Dynamics Simulations and Analysis
Z. Guo (2010)
10.1021/BI701295K
Myristoyl-based transport of peptides into living cells.
Allison R. Nelson (2007)
10.3109/02652040902751125
Preparation and in vitro–in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles
Eliza Główka (2010)
10.1016/S0005-2736(02)00399-1
A novel pH-sensitive liposome formulation containing oleyl alcohol.
J. Sudimack (2002)
10.1021/cr400031z
Multifaceted roles of disulfide bonds. Peptides as therapeutics.
Miriam Góngora-Benítez (2014)
10.1038/nature12959
An environmental bacterial taxon with a large and distinct metabolic repertoire
M. Wilson (2014)
10.1038/12469
Anti-cancer activity of targeted pro-apoptotic peptides
H. M. Ellerby (1999)
10.1016/J.ADDR.2003.10.037
"Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
E. Fattal (2004)
10.1016/j.copbio.2013.03.017
Beyond antibodies: using biological principles to guide the development of next-generation protein therapeutics.
Mihalis S Kariolis (2013)
10.1073/PNAS.0400219101
CIS display: In vitro selection of peptides from libraries of protein-DNA complexes.
Richard Odegrip (2004)
10.1016/j.ddtec.2011.07.004
Beyond cell penetrating peptides: designed molecular transporters.
P. Wender (2012)
10.1016/J.NANTOD.2015.11.003
Building Nanostructures with Drugs.
Wang Ma (2016)
10.1038/nature14098
A new antibiotic kills pathogens without detectable resistance
L. L. Ling (2015)
10.1172/JCI112580
Peptide growth factors and inflammation, tissue repair, and cancer.
M. Sporn (1986)
10.1016/j.molmed.2012.04.012
Cell-penetrating peptides: breaking through to the other side.
E. Koren (2012)
10.1038/nature10702
Rethinking amide bond synthesis
V. R. Pattabiraman (2011)
10.1021/JA038593B
Rational design of transglutaminase substrate peptides for rapid enzymatic formation of hydrogels.
Bi-Huang Hu (2003)
10.1016/j.biomaterials.2010.10.029
Light induced drug delivery into cancer cells.
Y. Shamay (2011)
10.1021/ja411811w
Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ.
Y. Yuan (2014)
10.1021/acs.orglett.6b01726
Oligomers of N-Substituted β(2)-Homoalanines: Peptoids with Backbone Chirality.
K. Lee (2016)
10.1002/bip.21533
Activity-based high-throughput determination of PTPs substrate specificity using a phosphopeptide microarray.
Liqian Gao (2010)
10.1021/ACSMACROLETT.5B00170
Enzyme-Specific Doxorubicin Drug Beacon as Drug-Resistant Theranostic Molecular Probes
Lye Lin Lock (2015)
10.1186/1471-2105-14-S2-S13
Prediction of peptides binding to MHC class I and II alleles by temporal motif mining
Cem Meydan (2013)
10.1016/j.jconrel.2015.12.006
Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Y. Zhao (2016)
10.1016/J.TET.2014.05.079
A disulfide bond replacement strategy enables the efficient design of artificial therapeutic peptides
K. Aoki (2014)
10.1021/co5001647
Facile solid-phase parallel synthesis of linear and cyclic peptoids for comparative studies of biological activity.
Shinae Park (2015)
10.1002/anie.201308875
Synthetic multivalent glycopeptide-lipopeptide antitumor vaccines: impact of the cluster effect on the killing of tumor cells.
H. Cai (2014)
10.1016/j.ijpharm.2011.08.034
Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles.
E. Ducat (2011)
10.1002/psc.1188
First selective agonist of the neuropeptide Y1‐receptor with reduced size
D. Zwanziger (2009)
10.1021/ja9088023
Elucidation of the self-assembly pathway of lanreotide octapeptide into beta-sheet nanotubes: role of two stable intermediates.
E. Pouget (2010)
10.7164/ANTIBIOTICS.42.591
Cyclosporins--new analogues by precursor directed biosynthesis.
R. Traber (1989)
10.1111/j.1600-0854.2007.00572.x
A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides
Falk Duchardt (2007)
10.1038/nmeth.1318
Enzymatic assembly of DNA molecules up to several hundred kilobases
D. Gibson (2009)
10.1021/BI035802W
Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Tomoyuki Kakudo (2004)
10.1021/JM9509410
De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity
Javadpour Mm (1996)
10.1002/anie.200906114
Closthioamide: an unprecedented polythioamide antibiotic from the strictly anaerobic bacterium Clostridium cellulolyticum.
T. Lincke (2010)
10.1002/adma.201504564
A General Strategy for Facile Synthesis and In Situ Screening of Self-Assembled Polymer-Peptide Nanomaterials.
Zengying Qiao (2016)
10.1021/JA051648K
Cell-Penetrating cis-γ-Amino-l-Proline-Derived Peptides
Josep Farrera-Sinfreu (2005)
10.1073/pnas.1730609100
Biomimetic organization: Octapeptide self-assembly into nanotubes of viral capsid-like dimension
C. Valéry (2003)
10.1038/srep26278
Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8
A. Gautam (2016)
10.1016/j.npep.2012.12.001
Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes
S. Hofmann (2013)
10.1096/fj.11-191536
Scavenger receptor‐mediated uptake of cell‐penetrating peptide nanocomplexes with oligonucleotides
Kariem Ezzat (2012)
10.1073/PNAS.91.19.9022
An in vitro polysome display system for identifying ligands from very large peptide libraries.
L. Mattheakis (1994)
10.1016/j.cbpa.2008.08.019
Contemporary strategies for the stabilization of peptides in the alpha-helical conformation.
Laura K. Henchey (2008)
10.1016/0006-2944(85)90135-8
Lectin-specific targeting of beta-glucocerebrosidase to different liver cells via glycosylated liposomes.
P. Das (1985)
10.1016/j.sbi.2007.08.012
Yeast surface display for protein engineering and characterization
S. Gai (2007)
10.1002/anie.201508716
A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53-Mediated Apoptosis.
M. Oh (2016)
10.1038/nchembio.664
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
T. White (2011)
10.1002/CHIN.201620266
Glycosylation, an Effective Synthetic Strategy to Improve the Bioavailability of Therapeutic Peptides
Shayli Varasteh Moradi (2016)
10.1038/nature09125
‘Umpolung’ Reactivity in Semiaqueous Amide and Peptide Synthesis
Bo Shen (2010)
10.1039/b923093a
The thermal and boron-catalysed direct amide formation reactions: mechanistically understudied yet important processes.
Hayley Charville (2010)
10.1038/srep11719
Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier
Hyo Young Kim (2015)
10.1371/journal.pone.0000972
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
Matthew C T Hartman (2007)
10.1038/ncomms3660
Visualization and targeted disruption of protein interactions in living cells
H. D. Herce (2013)
10.1039/c3cc48761j
Automated glycopeptide assembly by combined solid-phase peptide and oligosaccharide synthesis.
Mattan Hurevich (2014)
10.1139/bcb-2012-0097
Optimizing dimodular nonribosomal peptide synthetases and natural dipeptides in an Escherichia coli heterologous host.
M. A. Wyatt (2013)
10.1038/nm996
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis
J. Wadia (2004)
10.1016/j.ymben.2015.02.001
A stepwise increase in pristinamycin II biosynthesis by Streptomyces pristinaespiralis through combinatorial metabolic engineering.
L. Li (2015)
10.1074/jbc.M303045200
Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins*
Antonio Fittipaldi (2003)
10.1038/nature15739
Organometallic Palladium Reagents for Cysteine Bioconjugation
E. Vinogradova (2015)
10.1016/J.SBI.2007.07.004
Protein engineering with bacterial display.
P. Daugherty (2007)
10.1002/chem.200902452
How post-translational modifications influence amyloid formation: a systematic study of phosphorylation and glycosylation in model peptides.
Malgorzata Broncel (2010)
10.1021/ol502788e
Facile method to sequence cyclic peptides/peptoids via one-pot ring-opening/cleavage reaction.
K. Lee (2014)
10.1038/nchembio.2188
Polyketide and nonribosomal peptide retro-biosynthesis and global gene cluster matching.
Chris A Dejong (2016)
10.1093/nar/gkr072
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation
K. Ezzat (2011)
10.1039/c2cs35413f
Multivalent glyco(cyclo)peptides.
M. C. Galan (2013)
10.1002/adma.201404788
Tunable rigidity of (polymeric core)-(lipid shell) nanoparticles for regulated cellular uptake.
J. Sun (2015)
10.1021/JP1093614
Penetratin-Conjugated Gold Nanoparticles − Design of Cell-Penetrating Nanomarkers by Femtosecond Laser Ablation
Svea Petersen (2011)
10.1016/J.ADDR.2003.10.039
Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules.
M. Yessine (2004)
10.1016/S0168-3659(01)00277-2
Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C.
A. Kozłowski (2001)
10.1007/s11095-011-0440-7
Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration
T. Kanazawa (2011)
10.1021/JA00722A043
9-Fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting group
L. A. Carpino (1970)
10.1016/S1381-5148(99)00039-5
An efficient method for activation and recycling of trityl resins
M. Harré (1999)
10.1039/c0cc03272g
A simple strategy for the construction of combinatorial cyclic peptoid libraries.
J. Lee (2010)
10.1016/j.canlet.2014.09.016
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.
S. Shariat (2014)
10.1128/mBio.01379-14
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Y. Briers (2014)
10.1039/c001375g
On-resin peptide macrocyclization using thiol-ene click chemistry.
A. A. Aimetti (2010)
10.1002/PROT.340140411
Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library
K. O'Neil (1992)
10.1039/b919744c
Peptide-based activity-based probes (ABPs) for target-specific profiling of protein tyrosine phosphatases (PTPs).
Karunakaran Kalesh (2010)
10.1021/ol901370y
Reaction of thioacids with isocyanates and isothiocyanates: a convenient amide ligation process.
D. Crich (2009)
10.1002/adhm.201300037
A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing.
X. Ma (2013)
10.1093/nar/gkq1299
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo
Samir El Andaloussi (2011)
10.2174/1381612821666150901104821
Self-Assembling Peptide Nanofibrous Hydrogel as a Versatile Drug Delivery Platform.
Zhi-qiang Yu (2015)
10.1002/j.1460-2075.1988.tb02946.x
Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon‐induced Mx proteins.
H. Arnheiter (1988)
10.1016/S0040-4039(00)96384-6
Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin.
H. Rink (1987)
10.1002/anie.200705797
Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues.
Eric Biron (2008)
10.1021/NL061942Q
Squalenoyl nanomedicines as potential therapeutics.
P. Couvreur (2006)
10.1021/JA000563A
An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides
C. Schafmeister (2000)
10.1038/nature07033
Structural basis of specific tRNA aminoacylation by a small in vitro selected ribozyme
H. Xiao (2008)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1007/978-1-61779-379-0_19
Charging of tRNAs using ribozymes and selection of cyclic peptides containing thioethers.
P. C. Reid (2012)
10.1038/nrm2216
Pathways of clathrin-independent endocytosis
S. Mayor (2007)
10.1021/BI952757M
Lactam bridge stabilization of alpha-helices: the role of hydrophobicity in controlling dimeric versus monomeric alpha-helices.
M. E. Houston (1996)
10.1021/nn505688b
Multiwalled Nanotubes Formed by Catanionic Mixtures of Drug Amphiphiles
Yi-an Lin (2014)
10.1039/C4RA02458C
Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides
J. M. Palomo (2014)
10.1016/B978-0-12-396962-0.00001-X
Stapled peptides for intracellular drug targets.
G. Verdine (2012)
10.1093/nar/gkv1012
Genomes to natural products PRediction Informatics for Secondary Metabolomes (PRISM)
M. Skinnider (2015)
10.1021/ml300162r
Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases.
C. Olsen (2012)
10.1021/bc300585h
Cellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation site.
Pengcheng Zhang (2013)
10.1016/J.ADDR.2004.10.003
Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells.
J. Rothbard (2005)
10.1021/jo802097m
Peptide cyclization and cyclodimerization by Cu(I)-mediated azide-alkyne cycloaddition.
Reshma Jagasia (2009)
10.1021/ja710016v
Ribosomal Synthesis of N-Methyl Peptides
Alexander O. Subtelny (2008)
10.1038/ncomms9421
An automated Genomes-to-Natural Products platform (GNP) for the discovery of modular natural products
Chad W. Johnston (2015)
10.1093/nar/gkn991
DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways
Zengyi Shao (2009)
10.1016/J.ADDR.2004.10.005
Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
J. Wadia (2005)
10.1016/J.JMB.2006.03.017
Structural classification of small, disulfide-rich protein domains.
S. Cheek (2006)
10.1002/ANIE.200461150
Solid-phase synthesis of lipidated peptides.
G. Kragol (2004)
10.1007/s11095-007-9303-7
Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives
Leena N. Patel (2007)
10.1021/jacs.6b06253
Activation of Cell-Penetrating Peptides with Ionpair-π Interactions and Fluorophiles.
Nicolas Chuard (2016)
10.1038/nchembio.688
A natural prodrug activation mechanism in nonribosomal peptide synthesis.
Daniela Reimer (2011)
10.1039/c5np00099h
Recent advances in engineering nonribosomal peptide assembly lines.
M. Winn (2016)
10.1016/J.CBPA.2007.08.011
The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus.
Masaki Ohuchi (2007)
10.1002/JPS.20701
Synthesis and chemical stability of a disulfide bond in a model cyclic pentapeptide: cyclo(1,4)-Cys-Gly-Phe-Cys-Gly-OH.
H. He (2006)
10.1002/anie.201102572
Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters.
Deendayal Mandal (2011)
10.1016/j.chembiol.2015.08.008
Exploration of Nonribosomal Peptide Families with an Automated Informatic Search Algorithm.
Lian Yang (2015)
10.1021/bm500169p
Drug carriers for the delivery of therapeutic peptides.
A. W. Du (2014)
A proapoptotic peptide for the treatment of solid tumors.
J. Mai (2001)
10.1016/S0169-409X(00)00129-0
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
C. Lipinski (1997)
10.1586/era.11.109
Targeting the leptin receptor: a potential new mode of treatment for breast cancer
L. Otvos (2011)
10.1038/nrd1133
Large-scale manufacture of peptide therapeutics by chemical synthesis
By G. L. Bray (2003)
10.1211/jpp.59.8.0003
Novel, cell‐penetrating molecular transporters with flexible backbones and permanently charged side‐chains
N. Bodor (2007)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar